028300.KQ

N/A

HLB Co., Ltd. — PEG Ratio Analysis

—

PEG Ratio

Negative earnings — PE and PEG ratios are not meaningful

—

Current Price

$50800.00

TTM EPS

$-1476.07

P/E Ratio

—

Growth Rate

—

N/A

Sector

Healthcare

Biotechnology

Calculated

6/17/2026

9:22:03 AM

PEG Ratio Unavailable

Insufficient price/EPS data

Peer Comparison

Sample Size

3 peers

Industry Median PEG

4.34

25th Percentile

0.56

75th Percentile

6.38

Symbol	Company	PEG	P/E	Growth	vs 028300.KQ
128940.KS	Hanmi Pharm. Co., Ltd.	0.56	32.7	58.0%	—
068760.KQ	Celltrion Pharm, Inc.	4.34	52.3	12.0%	—
068270.KS	Celltrion, Inc.	6.38	28.9	4.5%	—

How to Interpret PEG Ratio

PEG < 1.0 — Potentially Undervalued. The stock may be priced below its earnings growth rate, suggesting a potential buying opportunity.

PEG 1.0–2.0 — Fairly Valued. The stock price is roughly in line with its earnings growth. A PEG of 1.0 is often considered "fair value."

PEG > 2.0 — Potentially Overvalued. The stock may be priced above what its earnings growth justifies.

Limitations:PEG ratios are less reliable for financial firms (earnings driven by interest margins), companies with negative/zero earnings growth, and hypergrowth companies (>100% growth) where the ratio may appear misleadingly low. Always use PEG alongside other valuation metrics.